Annika Y. Claßen

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

François-Xavier Lescure, Hitoshi Honda, Robert Fowler et al. · The Lancet Respiratory Medicine · 2021 · 246 citations · Full text

Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO)

Annika Y. Claßen, Larissa Henze, Marie von Lilienfeld‐Toal et al. · Annals of Hematology · 2021 · 83 citations · Full text

Phage Therapy in Germany—Update 2023

Christian Willy, Joachim J. Bugert, Annika Y. Claßen et al. · Viruses · 2023 · 42 citations · Full text

Translational Medicine, Antimicrobial Susceptibility, Health Sciences +15

Neurological symptoms and complications in predominantly hospitalized COVID‐19 patients: Results of the European multinational Lean European Open Survey on SARS‐Infected Patients (LEOSS)

Nina N. Kleineberg, Eileen Gülke, Hans O. Pinnschmidt et al. · European Journal of Neurology · 2021 · 31 citations · Full text

Intravenous and tablet formulation of posaconazole in antifungal therapy and prophylaxis: A retrospective, non-interventional, multicenter analysis of hematological patients treated in tertiary-care hospitals

Sebastian Heimann, Olaf Penack, Werner Heinz et al. · International Journal of Infectious Diseases · 2019 · 16 citations · Full text